CIK 0001837607 · <br>Emerging growth company
AEON Biopharma, Inc.
Sign in to watch- Ticker
- AEON
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853940478
- Phone
- (949) 354-6499
- Business address
- 130 VANTIS DRIVE, SUITE 170, ALISO VIEJO, CA, 92656
- Former names
- Priveterra Acquisition Corp.
- 4 Other disposition 10% owner disposed of 3,822 shares (other)
- 4 Open-market buy 10% owner bought 1,150,000 shares at $0.21 ($243,455)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 222,684 shares (grant or award)
- 4 Grant or award Director acquired 222,684 shares (grant or award)
- 4 Grant or award Director acquired 222,684 shares (grant or award)
- 4 Grant or award Director acquired 222,684 shares (grant or award)
- 4 Grant or award Director acquired 222,684 shares (grant or award)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 754,717 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CHIEF MEDICAL OFFICER acquired 2,179,372 shares (grant or award)
- 4 Grant or award CLO, CSO, and Corp Secretary acquired 2,179,372 shares (grant or award)
- 4 Grant or award PRINCIPAL ACCOUNTING OFFICER acquired 1,500,925 shares (grant or award)
- 4 Grant or award PRESIDENT & CEO acquired 3,000,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 1 of 4 · 76 filings